Experience with the ACURATE neo and neo2 transcatheter aortic valves in Spain. The PRECISA (PRospective Evaluation Complementing Investigation with ACURATE devices) registry.
Daniel Tébar MárquezXavier CarrilloBruno García Del BlancoJoan Antoni Gómez-HospitalLuis Nombela-FrancoEduardo MolinaGuillermo GaleoteVictoria VilaltaVicenc Serra-GarcíaGuillem Muntané CarolSantiago Jiménez-ValeroEduard Fernández-NofreriasÁlvaro Calabuig-GoenaAlfonso Jurado-RománÁngel Sánchez-RecaldeMaría Fernández VelascoLisardo BoscáRaul MorenoPublished in: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2024)
The use of ACURATE neo and neo2 transcatheter aortic valves is associated with satisfactory clinical results and an extremely low rate of complications. The ACURATE neo2 enables a significantly higher device success rate, primarily attributed to a significant reduction in the rate of PVL.